Novartis Loses Bid For Jury Trial In Famvir Patent Suit

Law360, New York (April 29, 2009, 12:00 AM EDT) -- A federal judge on Tuesday denied Novartis Pharmaceuticals Corp.'s bid for a jury trial in a patent infringement suit against Roxane Laboratories Inc. over herpes treatment Famvir, though the judge refused Roxane's request to toss the case entirely.

Judge Dennis M. Cavanaugh of the U.S. District Court for the District of New Jersey ruled Tuesday that Novartis did not have a right to trial by jury because the infringement action was based solely on Roxane’s filing of an abbreviated new drug application, limiting the claims for...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.